Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | wingless-type MMTV integration site family, member 3A | Starlite/ChEMBL | No references |
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Mus musculus | transient receptor potential cation channel, subfamily C, member 4 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | RAB9A, member RAS oncogene family | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | short transient receptor potential channel 6 | transient receptor potential cation channel, subfamily C, member 4 | 890 aa | 799 aa | 31.2 % |
Plasmodium falciparum | ras-related protein Rab-5B | RAB9A, member RAS oncogene family | 201 aa | 165 aa | 30.9 % |
Brugia malayi | Wnt-2 protein precursor | wingless-type MMTV integration site family, member 3A | 352 aa | 355 aa | 39.7 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0231 | 0.1524 | 0.4398 |
Onchocerca volvulus | 0.0202 | 0.124 | 0.5 | |
Echinococcus multilocularis | carbonic anhydrase II | 0.0427 | 0.3418 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.1267 | 0.3638 |
Schistosoma mansoni | carbonic anhydrase-related | 0.0231 | 0.1524 | 0.4398 |
Schistosoma mansoni | carbonic anhydrase-related | 0.0231 | 0.1524 | 0.4398 |
Schistosoma mansoni | carbonic anhydrase-related | 0.0231 | 0.1524 | 0.4398 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.0379 | 0.2956 | 0.3016 |
Loa Loa (eye worm) | hypothetical protein | 0.0231 | 0.1524 | 0.446 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1107 | 1 | 0.5 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.0231 | 0.1524 | 0.432 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.012 | 0.0453 | 0.1105 |
Onchocerca volvulus | Putative sulfate transporter | 0.0202 | 0.124 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.012 | 0.0453 | 0.1105 |
Echinococcus granulosus | transient receptor potential gamma protein | 0.0117 | 0.0422 | 0.1136 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0231 | 0.1524 | 0.432 |
Schistosoma mansoni | carbonic anhydrase | 0.0231 | 0.1524 | 0.4398 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.0274 | 0.1938 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0231 | 0.1524 | 0.446 |
Loa Loa (eye worm) | hypothetical protein | 0.0231 | 0.1524 | 0.446 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.0427 | 0.3418 | 0.5 |
Echinococcus granulosus | carbonic anhydrase | 0.0231 | 0.1524 | 0.4398 |
Echinococcus multilocularis | carbonic anhydrase | 0.0231 | 0.1524 | 0.4398 |
Echinococcus granulosus | carbonic anhydrase | 0.0231 | 0.1524 | 0.4398 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0427 | 0.3418 | 0.5 |
Echinococcus multilocularis | transient receptor potential gamma protein | 0.0117 | 0.0422 | 0.1136 |
Echinococcus granulosus | geminin | 0.0205 | 0.1267 | 0.3638 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.0427 | 0.3418 | 1 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0231 | 0.1524 | 0.432 |
Toxoplasma gondii | hypothetical protein | 0.0231 | 0.1524 | 0.5 |
Entamoeba histolytica | carbonic anhydrase, putative | 0.0274 | 0.1938 | 0.5 |
Schistosoma mansoni | transient receptor potential channel 4 | 0.0117 | 0.0422 | 0.1136 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0427 | 0.3418 | 1 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.0427 | 0.3418 | 1 |
Echinococcus multilocularis | transient receptor potential ion channel A | 0.0113 | 0.0384 | 0.1024 |
Echinococcus multilocularis | carbonic anhydrase | 0.0231 | 0.1524 | 0.4398 |
Schistosoma mansoni | carbonic anhydrase | 0.0274 | 0.1938 | 0.5621 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0231 | 0.1524 | 0.432 |
Echinococcus multilocularis | carbonic anhydrase | 0.0231 | 0.1524 | 0.4398 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.0422 | 0.1234 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0427 | 0.3418 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.012 | 0.0453 | 0.1324 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1107 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0082 | 0.0084 | 0.0137 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1267 | 0.3638 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.0084 | 0.0246 |
Brugia malayi | Carbonic anhydrase like protein 2 precursor | 0.0231 | 0.1524 | 0.432 |
Leishmania major | carbonic anhydrase-like protein | 0.0427 | 0.3418 | 1 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0427 | 0.3418 | 1 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0427 | 0.3418 | 1 |
Plasmodium falciparum | carbonic anhydrase | 0.0231 | 0.1524 | 0.5 |
Mycobacterium tuberculosis | Probable conserved transmembrane protein | 0.0233 | 0.1543 | 0.1263 |
Schistosoma mansoni | transient receptor potential channel | 0.0117 | 0.0422 | 0.1136 |
Echinococcus granulosus | transient receptor potential ion channel A | 0.0113 | 0.0384 | 0.1024 |
Echinococcus granulosus | carbonic anhydrase | 0.0231 | 0.1524 | 0.4398 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 0.0961 | 0.8587 | 1 |
Echinococcus granulosus | carbonic anhydrase II | 0.0427 | 0.3418 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0453 | 0.1324 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0231 | 0.1524 | 0.446 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0427 | 0.3418 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1267 | 0.3638 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | 0.376 uM | PUBCHEM_BIOASSAY: Confirmation dose response assay for compounds that inhibit transient receptor potential cation channel C4 (TRPC4). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2247, AID2256] | ChEMBL. | No reference |
EC50 (functional) | 0.944 uM | PUBCHEM_BIOASSAY: Confirmation dose response assay for compounds that activate transient receptor potential cation channel C4 (TRPC4). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2237, AID2259] | ChEMBL. | No reference |
IC50 (functional) | 4.3 uM | PubChem BioAssay. Dose response validation of uHTS Gli-SUFU antagonist hits in a Wnt3a luminescent reporter assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
IC50 (functional) | 20 uM | PubChem BioAssay. Dose response confirmation of uHTS antagonist hits from Gli-SUFU in a luminescent reporter assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.0058 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.3109 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 2.8184 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 3.1623 um | PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.6964 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 4.1095 uM | PubChem BioAssay. Nrf2 qHTS screen for inhibitors: Nrf2 A549 ARE-Fluc Confirmation Assay for Hit Validation. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.